Literature DB >> 2499247

Effects of elfamycins on elongation factor Tu from Escherichia coli and Staphylococcus aureus.

C C Hall1, J D Watkins, N H Georgopapadakou.   

Abstract

Six kirromycin analogs (elfamycins) were compared on the basis of their inhibition of Escherichia coli poly(U)-directed poly(Phe) synthesis and stimulation of elongation factor Tu (EF-Tu)-associated GTPase activity. The elfamycins tested were kirromycin, aurodox, efrotomycin, phenelfamycin A, unphenelfamycin, and L-681,217. The last three lack the pyridone ring present in the other elfamycins. All the elfamycins inhibited poly(U)-dependent poly(Phe) synthesis and stimulated EF-Tu-associated GTPase activity, suggesting that the pyridone ring is not essential for activity. The six elfamycins were also examined in a poly(U)-directed, poly(Phe)-synthesizing system derived from Staphylococcus aureus and had 50% inhibitory concentrations of greater than or equal to 1 mM. When S. aureus ribosomes and E. coli elongation factors were combined in a hybrid poly(Phe)-synthesizing system, aurodox produced essentially complete inhibition of poly(Phe) synthesis with a 50% inhibitory concentration of 0.13 microM. This suggests that the observed high MICs of kirromycin and its congeners in S. aureus reflect a kirromycin-resistant EF-Tu rather than permeability constraints.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2499247      PMCID: PMC171486          DOI: 10.1128/AAC.33.3.322

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Effect of kirromycin on elongation factor Tu. Location of the catalytic center for ribosome-elongation-factor-Tu GTPase activity on the elongation factor.

Authors:  G Chinali; H Wolf; A Parmeggiani
Journal:  Eur J Biochem       Date:  1977-05-02

2.  The molecular basis of kirromycin (mocimycin) action; a 1H NMR study using deuterated elongation factor Tu.

Authors:  J Barber; J A Carver; R Leberman; G M Tebb
Journal:  J Antibiot (Tokyo)       Date:  1988-02       Impact factor: 2.649

3.  L-681,217, a new and novel member of the efrotomycin family of antibiotics.

Authors:  A J Kempf; K E Wilson; O D Hensens; R L Monaghan; S B Zimmerman; E L Dulaney
Journal:  J Antibiot (Tokyo)       Date:  1986-10       Impact factor: 2.649

4.  Studies on the purification and properties of factor Tu from E. coli.

Authors:  D L Miller; H Weissbach
Journal:  Arch Biochem Biophys       Date:  1970-11       Impact factor: 4.013

Review 5.  Mechanism of action of kirromycin-like antibiotics.

Authors:  A Parmeggiani; G W Swart
Journal:  Annu Rev Microbiol       Date:  1985       Impact factor: 15.500

6.  Protein synthesis in a cell-free extract from Staphylococcus aureus.

Authors:  J C Mao
Journal:  J Bacteriol       Date:  1967-07       Impact factor: 3.490

7.  Synthetic analogs of aurodox and kirromycin active on elongation factor Tu from Escherichia coli.

Authors:  G Chinali
Journal:  J Antibiot (Tokyo)       Date:  1981-08       Impact factor: 2.649

8.  Kirromycin, an inhibitor of protein biosynthesis that acts on elongation factor Tu.

Authors:  H Wolf; G Chinali; A Parmeggiani
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

9.  Effects of the mutation glycine-222----aspartic acid on the functions of elongation factor Tu.

Authors:  G W Swart; A Parmeggiani; B Kraal; L Bosch
Journal:  Biochemistry       Date:  1987-04-07       Impact factor: 3.162

10.  Penicillin-binding proteins in a Staphylococcus aureus strain resistant to specific beta-lactam antibiotics.

Authors:  N H Georgopapadakou; S A Smith; D P Bonner
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

View more
  6 in total

1.  Rapid analysis of antibiotic-containing mixtures from fermentation broths by using liquid chromatography-electrospray ionization-mass spectrometry and matrix-assisted laser desorption ionization-time-of-flight-mass spectrometry.

Authors:  B L Ackermann; B T Regg; L Colombo; S Stella; J E Coutant
Journal:  J Am Soc Mass Spectrom       Date:  1996-12       Impact factor: 3.109

2.  Inhibition of bacterial protein synthesis by elongation-factor-Tu-binding antibiotics MDL 62,879 and efrotomycin.

Authors:  P Landini; M Bandera; B P Goldstein; F Ripamonti; A Soffientini; K Islam; M Denaro
Journal:  Biochem J       Date:  1992-05-01       Impact factor: 3.857

Review 3.  Comparison of Antibiotic Resistance Mechanisms in Antibiotic-Producing and Pathogenic Bacteria.

Authors:  Hiroshi Ogawara
Journal:  Molecules       Date:  2019-09-21       Impact factor: 4.411

4.  Bioconversion capacity of Streptomyces sp GE44282, a producer of the antibiotics heneicomycin and aurodox.

Authors:  F Marinelli; S Stella; N Montanini; F Le Monnier; L Cavaletti; E Selva
Journal:  J Ind Microbiol       Date:  1995-07

5.  Comparison of the Tu elongation factors from Staphylococcus aureus and Escherichia coli: possible basis for elfamycin insensitivity.

Authors:  C C Hall; J D Watkins; N H Georgopapadakou
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

6.  A population genomics approach to exploiting the accessory 'resistome' of Escherichia coli.

Authors:  Robert J Goldstone; David G E Smith
Journal:  Microb Genom       Date:  2017-04-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.